Abstract

Psychedelic research has witnessed a renaissance in recent years, and influential work on psychedelic substances has revealed their potential to unlock doors to human cognition as well as promising therapeutics for mental health. However, we still lack an understanding of the neurons and pathways these psychedelic substances modulate. This symposium takes a closer look at precisely this gap of knowledge in the field.

Speakers from basic science and clinical research will share their hypotheses and findings about neuronal mechanisms of psychedelic effects from animal models and human studies. Using a vast array of techniques, these scientists are unraveling novel insights about the action of psychedelics at the molecular, cellular, circuit, and system levels. A panel discussion at the end will help summarize and put the talks in perspective about the present research landscape in psychedelic neuroscience as well as future directions.

Symposium Format:

Scientific talks about advances in basic science and clinical research in Psychedelic Neuroscience followed by a panel discussion.

Time:  3 hours — Talks: 20 minutes with 5 minutes Q&A — Panel discussion: 30 minutes

Speakers/ Panelists — 1st September Symposium

Prof. Robert Malenka, Prof. Dr. David Olson, Prof. Kim Kuypers, Prof. Dietmar Schmitz, Dr. Torben Ott

Panel moderated by Dr. Prateep Beed